CLBNYSEOil & Gas Field Services, NECFiscal year ends December 31
Core Laboratories Inc. /DE/
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 30, 2026
$10.15+0.15 (+1.50%)
Close on Oct 19, 2026
- Market cap
- $475.81M
- P/E (TTM)
- 19.5
- Dividend yield
- 0.39%
Core Laboratories statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Oil & Gas Field Services, NEC companies for comparison
Valuation
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Market Cap | $465.73M | $958.03M |
| Enterprise Value | $562.95M | $1.17B |
| PE Ratio | 19.52 | 12.84 |
| PS Ratio | 0.90 | 1.79 |
| PB Ratio | 1.71 | 1.48 |
| P/TBV Ratio | 2.91 | 1.52 |
| P/FCF Ratio | 30.77 | 12.38 |
| P/OCF Ratio | 16.50 | 5.73 |
Enterprise value
| Measure | Core Laboratories | Industry median |
|---|---|---|
| EV / Sales | 1.08 | 2.23 |
| EV / EBITDA | 8.99 | 6.43 |
| EV / EBIT | 11.78 | 11.92 |
| EV / FCF | 37.19 | 14.65 |
Income (trailing twelve months)
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Revenue | $519.18M | $893.82M |
| Gross Profit | $101.32M | $263.25M |
| Operating Income | $47.80M | $37.73M |
| Pretax Income | $36.80M | $20.82M |
| Net Income | $24.35M | $2.91M |
| EBITDA | $62.65M | $104.88M |
| EPS (Diluted) | $0.52 | $0.23 |
Margins
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Gross Margin | 19.5% | 24.0% |
| Operating Margin | 9.21% | 9.34% |
| Pretax Margin | 7.09% | 5.01% |
| Profit Margin | 4.69% | 2.45% |
| EBITDA Margin | 12.1% | 19.8% |
| FCF Margin | 2.92% | 2.92% |
Returns
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Return on Equity (ROE) | 9.12% | 2.52% |
| Return on Assets (ROA) | 4.12% | 0.52% |
| Return on Invested Capital (ROIC) | 8.93% | 4.35% |
| Return on Capital Employed (ROCE) | 9.84% | 4.89% |
Growth
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 0.35% | 5.39% |
| Net Income Growth (YoY) | -17.8% | -23.7% |
| EPS Growth (YoY) | -17.5% | -24.0% |
| FCF Growth (YoY) | -64.0% | -19.7% |
| Revenue Growth (3Y CAGR) | 2.44% | 0.47% |
| EPS Growth (3Y CAGR) | 14.5% | -20.6% |
Balance sheet
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $22.74M | $37.22M |
| Total Debt | $113.86M | $1.13B |
| Net Cash (Debt) | -$91.13M | -$12.28M |
| Net Cash Per Share | -$1.99 | -$0.18 |
| Equity (Book Value) | $272.67M | $628.64M |
| Book Value Per Share | $5.94 | $9.88 |
| Tangible Book Value | $160.12M | $553.25M |
| Working Capital | $113.31M | $3.14M |
Financial position
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Current Ratio | 2.12 | 1.18 |
| Quick Ratio | 1.30 | 0.73 |
| Debt / Equity | 0.42 | 0.42 |
| Debt / EBITDA | 1.82 | 1.82 |
| Debt / FCF | 7.52 | 2.32 |
| Net Debt / EBITDA | 1.45 | 1.13 |
| Interest Coverage | 4.35 | 2.02 |
Cash flow (trailing twelve months)
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Operating Cash Flow | $28.22M | $192.72M |
| Capital Expenditures | -$13.09M | -$170.35M |
| Free Cash Flow | $15.14M | $16.47M |
| FCF Per Share | $0.33 | $0.25 |
Efficiency
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Asset Turnover | 0.88 | 0.39 |
| Inventory Turnover | 7.10 | 10.85 |
| Revenue Per Employee | $157.33K | $1.62M |
| Profits Per Employee | $7.38K | $6.39K |
| Employee Count | 3,300 | 281 |
Dividends and yields
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Earnings Yield | 5.23% | 0.45% |
| FCF Yield | 3.25% | 2.84% |
| Dividend Yield | 0.39% | 2.03% |
| Buyback Yield | 3.08% | 0.32% |
| Shareholder Yield | 3.48% | 1.94% |
| Dividend Per Share | $0.04 | $0.60 |
| Dividend Growth (YoY) | 0.00% | 0.00% |
| Years of Dividend Growth | 0 | 0 |
| Payout Ratio | 7.60% | 38.3% |
| FCF Payout Ratio | 12.2% | 32.6% |
Shares
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Shares Outstanding | 45,884,500 | 105,192,000 |
| Shares Change (YoY) | -1.91% | 1.06% |
| Shares Change (QoQ) | -0.36% | 0.02% |
| Float | 45,216,800 | 76,585,800 |
| Shares Held by Insiders | 1.46% | 9.89% |
| Shares Held by Institutions | 114.8% | 69.2% |
Taxes
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Income Tax | $12.10M | $7.40M |
| Effective Tax Rate | 32.9% | 21.8% |
Scores
| Measure | Core Laboratories | Industry median |
|---|---|---|
| Graham Number | $8.34 | $28.76 |
| Graham Upside | -17.8% | -4.02% |
| Altman Z-Score | 2.71 | 1.60 |
| Piotroski F-Score | 7 | 5 |
Calculated by StockData from Core Laboratories's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.